Text Size
25 studies found for:    "Li Fraumeni syndrome"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Conditions: Breast Neoplasms;   Ovarian Neoplasms
Intervention:
22 Recruiting A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
Condition: Non-muscle Invasive Bladder Cancer
Interventions: Biological: ALT-801;   Drug: Gemcitabine
23 Recruiting A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Conditions: Transitional Cell Carcinoma of Bladder;   Urethra Cancer;   Ureter Cancer;   Malignant Tumor of Renal Pelvis
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Biological: ALT-801
24 Recruiting A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma
Condition: Relapsed or Refractory Multiple Myeloma
Intervention: Biological: ALT-801
25 Withdrawn Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course
Condition: Acute Myelogenous Leukemia
Interventions: Drug: cenersen;   Drug: placebo;   Drug: idarubicin and cytarabine (chemotherapy)
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-25) Next Page
† Indicates status has not been verified in more than two years